Premium
Pioglitazone: inexpensive; very effective at reducing HbA 1c ; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit
Author(s) -
Ryder Robert E. J.,
DeFronzo Ralph A.
Publication year - 2019
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/dme.14053
Subject(s) - medicine , citation , pioglitazone , library science , family medicine , diabetes mellitus , computer science , type 2 diabetes , endocrinology